EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study

Saahith Garg, Dhriti Kumar, Ananya Surabhi, Adishwar Rao, Akriti Agrawal, Dhruv Kumar, Arnav Garyali, Elakiya Jayaraman, Rishi Panjala, Elsbeth Chow, Trishna Parikh, Shilpa Chitnis und 2 weitere

Clinics and Practice · 18.11.2026 · 16 (11) · 218

DOI: 10.3390/clinpract16110218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 18.11.2026. Verfasst von Saahith Garg und 13 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Transverse myelitis (TM) and acute disseminated encephalomyelitis (ADEM) are debilitating neurological conditions. We aimed to examine in-hospital mortality and readmissions in patients hospitalized with TM and/or ADEM.

Methods

In this retrospective study, we analyzed the Nationwide Readmissions Database from 2010 to 2020, excluding 2015, to identify index hospitalizations for TM and/or ADEM. Patients were stratified according to in-hospital mortality status. We used the Pearson chi-square test and Wilcoxon rank-sum test to compare baseline characteristics, while multivariable logistic regression analysis was used to identify predictors of in-hospital mortality.

Results

Of 50,357 patients hospitalized with TM and/or ADEM, 1236 (2.5%) did not survive index hospitalization. Nonsurvivors were older with longer lengths of stay and a higher comorbidity burden. Among those ≥45 years, there was a trend towards increased odds of in-hospital mortality. Infection-related factors were associated with increased odds of in-hospital mortality, including streptococcal infection (odds ratio [OR]: 5.45 [1.07–27.68], p = 0.04) and coronavirus disease 2019 (OR: 4.54 [2.51–8.19], p < 0.001). Stroke (OR 2.71 [2.11–3.48], p < 0.001) and congestive heart failure (OR 2.17 [1.66–2.85], p < 0.001) emerged as the strongest predictors amongst chronic comorbidities. Over the study period, 5301 (11.8%) patients were readmitted to the hospital within 30 days.

Conclusions

In patients with TM and/or ADEM, in-hospital mortality was associated with older age, greater comorbidity burden, and concurrent infections, particularly COVID-19 and streptococcal infections. These findings highlight opportunities for prevention, early detection, and management strategies to improve outcomes for patients with TM and/or ADEM.

Zitieren

APA

Garg, S., Kumar, D., Surabhi, A., Rao, A., Agrawal, A., Kumar, D., Garyali, A., Jayaraman, E., Panjala, R., Chow, E., Parikh, T., Chitnis, S., Mir, M., & Young, A. (2026). Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study. Clinics and Practice, 16(11), 218. https://doi.org/10.3390/clinpract16110218

Vancouver

Garg S, Kumar D, Surabhi A, Rao A, Agrawal A, Kumar D, et al. Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study. Clinics and Practice. 2026;16(11):218. doi:10.3390/clinpract16110218

BibTeX
@article{Garg2026,
  author = {Garg, Saahith and Kumar, Dhriti and Surabhi, Ananya and Rao, Adishwar and Agrawal, Akriti and Kumar, Dhruv and Garyali, Arnav and Jayaraman, Elakiya and Panjala, Rishi and Chow, Elsbeth and Parikh, Trishna and Chitnis, Shilpa and Mir, Mahnoor and Young, Alisha},
  title = {Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study},
  journal = {Clinics and Practice},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {218},
  doi = {10.3390/clinpract16110218}
}
Kostenlos starten →